Invention Grant
- Patent Title: Glucosamine pro-drug
- Patent Title (中): 葡糖胺前药
-
Application No.: US13622516Application Date: 2012-09-19
-
Publication No.: US08772227B2Publication Date: 2014-07-08
- Inventor: Fahkreddin Jamali , Kamalijit Kaur , Mohammadhossien Gilzad
- Applicant: Fahkreddin Jamali , Kamalijit Kaur , Mohammadhossien Gilzad
- Agent William J. Bundren
- Main IPC: A61K47/48
- IPC: A61K47/48
Abstract:
To develop glucosamine (GlcN) pro-drugs with properties superior to the presently available GlcN products, we have synthesized derivatives with improved pharmaceutical properties. The synthesized derivatives include peptide-GlcN ester and amide conjugates where the peptide portion consists of one or more amino acids. One such compound is (5-amino-3,4,6-trihydroxyoxan-2-yl)methyl 2-(2-aminoacetamido)-3-methylbutanoate or glycine-valine-COO-GlcN (GV-GlcN).7.
Public/Granted literature
- US20130196897A1 Glucosamine Pro-drug Public/Granted day:2013-08-01
Information query
